Vcaps® Enteric Capsule Technology
Vcaps® Enteric is a fully compliant capsule technology that simplifies drug enteric delivery implementation from early stage development to commercial manufacturing. Vcaps Enteric capsules have been evaluated in-vitro and in-vivo across a number of compounds, and have proven full compliance with relevant EP, JP and US Pharmacopeia monographs. By removing the need for enteric coating, Vcaps® Enteric capsules offer tremendous potential in early stage product development, greatly simplifying formulation and process development as well as scale-up and validation. Intrinsically enteric capsule technologies also provide product differentiation and life cycle management opportunities.
Contact Details:
Company name: Capsugel
Website: www.capsugel.com/biopharmaceutical-products/vcaps-enteric-capsules
E-mail: solutions.emea@capsugel.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
